INDIVIDUAL TEST 029

Scl-100 antibodies

Indication

Scl-100 is included in analysis ENA screen. See therefore “ENA screen” for indication, method, answer and reference range.

Interpretation

Positive in about 15% of patients with scleroderma, especially with the systemic progressive form (diffuse progressive systemic sclerosis). Patients with Raynaud’s syndrome and positive anti Scl-100 often later develop typical diffuse progressive systemic scleroderma.

More information

Learn more about sampling.
> Read more

Download request forms

Autoimmune diagnostics

ENSKILD ANALYS 029

Scl-100-antikroppar

Scl-100 ingår i analysen ENA screen. Se därför ENA screen för indikation, metod och svar.

Tolkning

Positiv hos ca 15% av patienterna med sclerodermi, speciellt vid den systemiska progressiva formen (diffuse progressive systemic sclerosis). Patienter med Raynauds syndrom och positiv anti Scl-100 utvecklar ofta senare typisk diffus progressiv systemisk sclerodermi.

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Autoimmun diagnostik